Treatment Options in Multiple Myeloma

What are the treatment options for patients with multiple myeloma? Part four of the Myeloma Series delves into the pharmacology of the disease with special guest Kathryn Maples, PharmD, BCOP, who is a clinical pharmacy specialist in Multiple Myeloma at the Winship Cancer Institute of Emory Healthcare in Atlanta, Georgia.

The episode features discussions on triplet regimens, bortezomib, lenolidomide, subcutaneous verus intravenous daratumumab, and more.